First Trust Advisors LP Spring Works Therapeutics, Inc. Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 13,097 shares of SWTX stock, worth $756,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,097
Previous 10,982
19.26%
Holding current value
$756,482
Previous $351,000
34.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$413 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$325 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$200 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$189 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$173 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.6B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...